Studies have shown that dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) is a potential cancer therapeutic target, as it regulates the cell cycle by influencing the expression of oncogenes and tumor suppressor genes (36). The gene discussed is DYRK1A; the disease is cancer.